Franklin Resources Inc. Grows Holdings in HealthEquity, Inc. (NASDAQ:HQY)

Franklin Resources Inc. lifted its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 0.7% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,640,215 shares of the company’s stock after buying an additional 11,659 shares during the quarter. Franklin Resources Inc. owned approximately 1.88% of HealthEquity worth $139,369,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of the company. Wasatch Advisors LP increased its stake in HealthEquity by 6.6% during the 3rd quarter. Wasatch Advisors LP now owns 7,758,890 shares of the company’s stock valued at $635,065,000 after purchasing an additional 483,269 shares in the last quarter. Mackenzie Financial Corp increased its stake in HealthEquity by 16.0% during the 2nd quarter. Mackenzie Financial Corp now owns 2,364,521 shares of the company’s stock valued at $203,822,000 after purchasing an additional 325,906 shares in the last quarter. Generate Investment Management Ltd bought a new stake in HealthEquity during the 2nd quarter valued at about $24,184,000. Vaughan Nelson Investment Management L.P. boosted its holdings in shares of HealthEquity by 36.7% during the 3rd quarter. Vaughan Nelson Investment Management L.P. now owns 843,423 shares of the company’s stock valued at $69,034,000 after acquiring an additional 226,563 shares during the last quarter. Finally, Thrivent Financial for Lutherans boosted its holdings in shares of HealthEquity by 924.2% during the 2nd quarter. Thrivent Financial for Lutherans now owns 220,220 shares of the company’s stock valued at $18,983,000 after acquiring an additional 198,718 shares during the last quarter. Institutional investors own 99.55% of the company’s stock.

Analyst Ratings Changes

HQY has been the topic of a number of recent analyst reports. Royal Bank of Canada raised their price target on shares of HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a report on Tuesday, December 10th. Deutsche Bank Aktiengesellschaft raised their price objective on shares of HealthEquity from $102.00 to $103.00 and gave the stock a “buy” rating in a report on Wednesday, September 4th. BTIG Research raised their price objective on shares of HealthEquity from $110.00 to $130.00 and gave the stock a “buy” rating in a report on Thursday, November 14th. Bank of America raised their price objective on shares of HealthEquity from $100.00 to $120.00 and gave the stock a “buy” rating in a report on Wednesday, November 13th. Finally, Mizuho started coverage on shares of HealthEquity in a report on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 price objective on the stock. One analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $110.71.

Insider Buying and Selling

In other HealthEquity news, Director Frank Corvino sold 1,247 shares of HealthEquity stock in a transaction on Tuesday, October 1st. The shares were sold at an average price of $80.26, for a total transaction of $100,084.22. Following the completion of the transaction, the director now directly owns 4,823 shares of the company’s stock, valued at $387,093.98. The trade was a 20.54 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Robert W. Selander sold 8,250 shares of HealthEquity stock in a transaction on Monday, December 9th. The stock was sold at an average price of $101.56, for a total transaction of $837,870.00. Following the transaction, the director now directly owns 66,469 shares of the company’s stock, valued at $6,750,591.64. The trade was a 11.04 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 43,786 shares of company stock worth $4,140,387. Insiders own 2.20% of the company’s stock.

HealthEquity Trading Up 0.7 %

Shares of HQY opened at $95.62 on Monday. The company’s fifty day moving average is $94.06 and its 200 day moving average is $84.26. HealthEquity, Inc. has a fifty-two week low of $62.10 and a fifty-two week high of $105.82. The stock has a market capitalization of $8.29 billion, a PE ratio of 87.72, a P/E/G ratio of 1.10 and a beta of 0.55. The company has a debt-to-equity ratio of 0.51, a quick ratio of 4.10 and a current ratio of 3.20.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.